Carried by: BRAINTEAM
References:
Clinician(s): Gaël NICOLAS
Biologist(s): Gaël NICOLAS

Presentation

This preindication aims to unify a significant number of rare diseases that include cerebral calcifications as a phenotypic gateway, providing a critical element for interpreting sequencing data. The clinical presentation can be heterogeneous, and widespread access to brain imaging makes it possible to identify a clinical-radiological entity that will facilitate interpretation.

Criteria before considering a discussion in MDM-FMG

Patients presenting neurological and/or psychiatric symptoms related to:

  • Cerebral calcifications affecting at least the basal ganglia,
    • of greater extent and severity than would be expected for their age (if necessary: TCS visual scan scale and normative data: Nicolas et al., Brain 2013),
    • and in the absence of calcium-phosphorus metabolism disorders (at least: PTH, blood vitamin D, calcium, phosphorus)
  • OR calcifications of the white matter and/or cerebral cortex in the absence of calcifications of the basal ganglia
  • OR pontocerebellar calcifications in the absence of calcifications of the basal ganglia
  • Excluding clinically severe paediatric forms (current age < 5 years)

Genome Sequencing in diagnostic strategy

MDM cartography

MDM
Type of the MDM
City of the coordinator
Name, first name, and email of the contact

MDM Neurogenetics Paris Pitié

Regional, National Adult
Paris

MDM Neurogenetics Paris Trousseau

Regional, National Pediatric
Paris

Diana RODRIGUEZ

diana.rodriguez@aphp.fr

Lydie BURGLEN

lydie.burglen@aphp.fr

MDM Neurogenetics Angers

Interregional
Angers

Christophe VERNY

chverny@chu-angers.fr

Virginie PICHON

virginie.pichon@chu-angers.fr

MDM Neurogenetics Bordeaux

Interregional
Bordeaux

MDM Neurogenetics Strasbourg

Interregional
Strasbourg

MDM Neurogenetics Montpellier

Interregional
Montpellier

MDM Neurogenetics Lille

Interregional
Lille